SPT Labtech and EMBL GeneCore Partner to Advance Automated Genomics Workflows
The collaboration focuses on implementing a liquid handling platform to streamline end-to-end laboratory processes and protocol development.
The collaboration focuses on implementing a liquid handling platform to streamline end-to-end laboratory processes and protocol development.
A national eMERGE study found that genetic risk results can be returned at scale, with over 70% of high-risk patients receiving counseling, though disparities in access persist, according to the American Journal of Human Genetics.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
The accreditation covers liver health diagnostics, including Hepatotrack, a molecular diagnostic liquid biopsy that is predictive of acute liver rejection post-liver transplant.
State audit finds the lab billed for drug tests without required physician signatures in nearly a quarter of reviewed instances.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Agilent Technologies will acquire Biocare Medical for $950 million in cash, adding more than 300 specialized antibodies and expanding Agilent’s pathology and immunohistochemistry offerings, according to the companies.
Analysis of international surveillance data shows rising resistance to last-line antibiotics, with significant regional variations in treatment outcomes.